{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:22:27Z","timestamp":1793226147819,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.antiviral.2005.08.006","type":"journal-article","created":{"date-parts":[[2005,11,11]],"date-time":"2005-11-11T07:14:42Z","timestamp":1131693282000},"page":"31-38","source":"Crossref","is-referenced-by-count":166,"title":["Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses"],"prefix":"10.1016","volume":"69","author":[{"given":"Eva","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Pavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolie","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Lobigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2005.08.006_bib1","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.32.11.1742","article-title":"Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus","volume":"32","author":"Baba","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2005.08.006_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-3542(02)00209-7","article-title":"Susceptibility to highly sulphated glycosaminoglycans of human immunodeficiency virus type 1 replication in peripheral blood lymphocytes and monocyte-derived macrophages cell cultures","volume":"58","author":"Bartolini","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2005.08.006_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1146\/annurev.biochem.68.1.729","article-title":"Functions of cell surface heparan sulfate proteoglycans","volume":"68","author":"Bernfield","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.antiviral.2005.08.006_bib4","series-title":"Fields Virology","first-page":"1043","article-title":"Flaviviruses","author":"Burke","year":"2001"},{"key":"10.1016\/j.antiviral.2005.08.006_bib5","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm0897-866","article-title":"Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate","volume":"3","author":"Chen","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2005.08.006_bib6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrmicro975","article-title":"Antivirals and antiviral strategies","volume":"2","author":"De Clercq","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0008-6215(01)00300-7","article-title":"Determination of the composition of the oligosaccharide phosphate fraction of Pichia (Hansenula) holstii NRRL Y-2448 phosphomannan by capillary electrophoresis and HPLC","volume":"337","author":"Ferro","year":"2002","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.antiviral.2005.08.006_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5694\/j.1326-5377.1952.tb74985.x","article-title":"Murray Valley encephalitis isolation and characterization of the aetiological agent","volume":"1","author":"French","year":"1952","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.antiviral.2005.08.006_bib9","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1016\/S0264-410X(03)00269-X","article-title":"A BHK-21 cell culture-adapted tick-borne encephalitis virus mutant is attenuated for neuroinvasiveness","volume":"21","author":"Goto","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2005.08.006_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0966-842X(01)02288-0","article-title":"Epidemic dengue\/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century","volume":"10","author":"Gubler","year":"2002","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib11","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1099\/0022-1317-71-12-2923","article-title":"Epitope analysis of the envelope and non-structural glycoproteins of Murray Valley encephalitis virus","volume":"71","author":"Hall","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.73.1.783-786.1999","article-title":"New mouse model for dengue virus vaccine testing","volume":"73","author":"Johnson","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib13","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.4049\/jimmunol.168.10.5233","article-title":"Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4","volume":"168","author":"Johnson","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4049\/jimmunol.172.1.20","article-title":"Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through toll-like receptor 4","volume":"172","author":"Johnson","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib15","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1038\/sj.onc.1208602","article-title":"A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer","volume":"24","author":"Joyce","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2005.08.006_bib16","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the north-eastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2005.08.006_bib17","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1128\/JVI.78.15.8271-8280.2004","article-title":"Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses","volume":"78","author":"Lee","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib18","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1128\/JVI.74.19.8867-8875.2000","article-title":"Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry","volume":"74","author":"Lee","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib19","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1128\/JVI.76.10.4901-4911.2002","article-title":"Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus","volume":"76","author":"Lee","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib20","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1128\/JVI.76.7.3202-3211.2002","article-title":"Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice","volume":"76","author":"Licon Luna","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0166-3542(02)00095-5","article-title":"Heparin inhibits dengue-2 virus infection of five human liver cell lines","volume":"56","author":"Lin","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2005.08.006_bib22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/icb.1986.61","article-title":"Genetic differentiation of Murray Valley encephalitis virus in Australia and Papua New Guinea","volume":"64","author":"Lobigs","year":"1986","journal-title":"Aust. J. Exp. Biol. Med. Sci."},{"key":"10.1016\/j.antiviral.2005.08.006_bib23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0042-6822(90)90029-Q","article-title":"Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence","volume":"176","author":"Lobigs","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2005.08.006_bib24","doi-asserted-by":"crossref","first-page":"11208","DOI":"10.1016\/S0021-9258(19)78112-5","article-title":"Liver heparan sulfate structure. A novel molecular design","volume":"269","author":"Lyon","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2005.08.006_bib25","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2005.08.006_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01321074","article-title":"Arboviruses causing human disease in the Australasian zoogeographic region","volume":"136","author":"Mackenzie","year":"1994","journal-title":"Arch. Virol."},{"issue":"Suppl. 17","key":"10.1016\/j.antiviral.2005.08.006_bib27","first-page":"186","article-title":"Experimental and clinical pharmacology of pentosan polysulfate","volume":"2","author":"Maffrand","year":"1991","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.antiviral.2005.08.006_bib28","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1128\/JVI.75.12.5627-5637.2001","article-title":"Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo","volume":"75","author":"Mandl","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib29","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1021\/jm000412i","article-title":"Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors","volume":"44","author":"Marks","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2005.08.006_bib30","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2005.08.006_bib31","first-page":"105","article-title":"Japanese encephalitis vaccines: current vaccines and future prospects","volume":"267","author":"Monath","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-3542(96)89697-5","article-title":"Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections","volume":"30","author":"Neyts","year":"1996","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2005.08.006_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.antiviral.2004.01.001","article-title":"The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus","volume":"63","author":"Nyberg","year":"2004","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2005.08.006_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-3542(03)00175-X","article-title":"In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain)","volume":"60","author":"Ono","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2005.08.006_bib35","first-page":"3433","article-title":"Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity","volume":"59","author":"Parish","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2005.08.006_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2\u00c5 resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2005.08.006_bib37","first-page":"1567","article-title":"Strategies for the identification of inhibitors of West Nile virus and other flaviviruses","volume":"3","author":"Shi","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.antiviral.2005.08.006_bib38","first-page":"171","article-title":"Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections","volume":"267","author":"Solomon","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2005.02.001","article-title":"The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell","volume":"66","author":"Talarico","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2005.08.006_bib40","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1099\/0022-1317-82-8-1885","article-title":"Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism","volume":"82","author":"Thullier","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib41","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/JVI.69.8.4792-4796.1995","article-title":"Antiviral defense in mice lacking both alpha\/beta and gamma interferon receptors","volume":"69","author":"van den Broek","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib42","first-page":"177","article-title":"Recent research on the biological activity of suramin","volume":"45","author":"Voogd","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.antiviral.2005.08.006_bib43","doi-asserted-by":"crossref","first-page":"13323","DOI":"10.1128\/JVI.77.24.13323-13334.2003","article-title":"CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis","volume":"77","author":"Wang","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jlb.66.3.391","article-title":"Modulation of macrophage and B cell function by glycosaminoglycans","volume":"66","author":"Wrenshall","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.antiviral.2005.08.006_bib45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0223-5234(02)01347-8","article-title":"Preparation and anticoagulant activity of the phosphosulfomannan PI-88","volume":"37","author":"Yu","year":"2002","journal-title":"Eur. J. Med. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635420500210X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635420500210X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T11:15:03Z","timestamp":1626693303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635420500210X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S016635420500210X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2005.08.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}